1974
DOI: 10.1016/0006-2952(74)90552-8
|View full text |Cite
|
Sign up to set email alerts
|

Effects of theophylline and propranolol on acetylcholine-induced release of adrenal medullary catecholamines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
9
0

Year Published

1975
1975
1991
1991

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(10 citation statements)
references
References 18 publications
1
9
0
Order By: Relevance
“…In this context the controls with isoprenaline seemed important in that postjunctional a*-adrenoceptors in some locations have been reported to inhibit end-organ activity (see Langer 19811, particularly when it is mediated via the adenylate cyclase system, which is the case for amylase secretion from salivary glands (Butcher et dine reduced it to the low level otherwise seen only after B-adrenoceptor block (Gjorstrup 1979 a ) , suggesting that possibly the chromafin cells of the adrenal medulla of the rabbit are endowed with prejunctional a-adrenoceptors. The present evidence for a prejunctional a-adrenoceptor mediated control of catecholamine release from the rabbit adrenals is circumstantial, but is in accordance with earlier observations (Gutman & Bonnyaviro 1974, Serck-Hanssen 1974, Starke et al 1974.…”
Section: Discussionsupporting
confidence: 92%
“…In this context the controls with isoprenaline seemed important in that postjunctional a*-adrenoceptors in some locations have been reported to inhibit end-organ activity (see Langer 19811, particularly when it is mediated via the adenylate cyclase system, which is the case for amylase secretion from salivary glands (Butcher et dine reduced it to the low level otherwise seen only after B-adrenoceptor block (Gjorstrup 1979 a ) , suggesting that possibly the chromafin cells of the adrenal medulla of the rabbit are endowed with prejunctional a-adrenoceptors. The present evidence for a prejunctional a-adrenoceptor mediated control of catecholamine release from the rabbit adrenals is circumstantial, but is in accordance with earlier observations (Gutman & Bonnyaviro 1974, Serck-Hanssen 1974, Starke et al 1974.…”
Section: Discussionsupporting
confidence: 92%
“…In others, it enhanced the nicotinic secretory response or had no effect (Adams & Boarder, 1987;Higgins & Berg, 1988;Morita et al, 1987a,b). Similar contradictory data have been obtained with other drugs that affect cellular adenosine 3': 5'-cyclic monophosphate (cyclic AMP) levels, such as phosphodiesterase inhibitors, or that mimic the actions of cyclic AMP, such as the permeant analogues 8-bromo-and dibutyryl-cyclic AMP (Adams & Boarder, 1987;Marriott et al, 1988;Morita et al, 1985;Tsujimoto et al, 1986;Serck-Hanssen, 1974). The cause of the discrepancies between these studies remains unclear but may include different concentrations or timecourses of cyclic AMP generated in the cells by the procedures used and the different types and concentrations of secretagogues used to evoke catecholamine secretion (see for example Morita et al, 1987a,b;Marriott et al, 1988).…”
Section: Introductionmentioning
confidence: 87%
“…In addition, propranolol significantly reduced the enhancement in noradrenaline release elicited by papaverine, even though the granular effect' induced by the phosphodiesterase inhibitor in the presence of propranolol was more pronounced than that observed in the absence of the 3-blocking agent. Yet, this concentration of proprano- Hanssen, 1974) and the guinea-pig vas deferens (Wooten et al, 1973) in the absence of extracellular calcium. It is possible that cyclic AMP may facilitate noradrenaline release by mobilizing intracellular bound calcium and thus increasing the availability of calcium for the stimulation secretion coupling.…”
Section: Discussionmentioning
confidence: 99%